1.	Phase II Randomized Pilot Study of Sequential Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, and Sargramostim (GM-CSF) With Standard Adjuvant Chemotherapy in Women With High-Risk Stage II or III Breast Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-03-C-0005, NCI-5191, 5191, NCT00052351
2.	Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000068427, P30CA051008, GUMC-00101, GUMC-IBC20-09, NIH/OBA-0006-405, NCI-833, 833, NCT00009958
3.	Pilot Study of Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, Recombinant Fowlpox GM-CSF Vaccine, and Radiotherapy in Patients With Carcinoembryonic Antigen-Positive Solid Tumors Metastatic to the Liver Phase: No phase specified Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-04-C-0167, 6368, NCI-6368, NCT00085241
4.	Pilot Study of Vaccinia-CEA-TRICOM Vaccine, Fowlpox-CEA-TRICOM Vaccine, and Recombinant Fowlpox GM-CSF Vaccine With Paclitaxel, Carboplatin, and Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer Phase: No phase specified Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-04-C-0252, NCI-6439, 6439, NCT00091039